ResearcherUniversity of Kansas Medical CenterNo recent work listed

Qi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5894-6331; OpenAlex author ID A5100340123. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuelong Liang · 1 shared paper, 2022 · strength 0.15
- Paper Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progr… DOI 10.3389/fendo.2022.865655 ↗
Yiyin Zhang · 1 shared paper, 2022 · strength 0.15
- Paper Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progr… DOI 10.3389/fendo.2022.865655 ↗
Tianyu Lin · 1 shared paper, 2022 · strength 0.15
- Paper Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progr… DOI 10.3389/fendo.2022.865655 ↗
Jun Yu · 1 shared paper, 2014 · strength 0.09
- Paper Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer. DOI 10.1177/1534735414532010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.